BioMarin to Participate in Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 in Rancho Palos Verdes,...
June 05 2019 - 08:30AM
PR Newswire (US)
SAN RAFAEL, Calif.,
June 5, 2019 /PRNewswire/ -- BioMarin
Pharmaceutical Inc. (NASDAQ: BMRN) today announced that
Henry Fuchs, M.D., President,
Worldwide Research & Development, will present at the Goldman
Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 at 8:40am
PT/11:40am ET in Rancho Palos Verdes, California. To
access the live webcast, please visit the investor section of the
BioMarin website, www.biomarin.com. A replay will also be archived
on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for patients with serious and
life-threatening rare and ultra-rare genetic diseases. The
Company's portfolio consists of several commercial products and
multiple clinical and pre-clinical product candidates for the
treatment of various diseases. For additional information, please
visit www.biomarin.com.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-goldman-sachs-40th-annual-global-healthcare-conference-on-tuesday-june-11-in-rancho-palos-verdes-ca-300862195.html
SOURCE BioMarin Pharmaceutical Inc.
Copyright 2019 PR Newswire
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Feb 2024 to Mar 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2023 to Mar 2024